Video

MaxCyte, Inc. Cell & Gene Tech Expo August 2025: Cell Therapy

Source: MaxCyte, Inc.

Cell and gene therapies are revolutionizing treatments for cancer and other serious diseases, but immune cell engineering remains difficult due to their sensitivity and resistance to standard transfection. MaxCyte’s ExPERT™ electroporation platform offers a highly efficient, scalable solution for delivering mRNA, DNA, and CRISPR-Cas9 RNPs into hard-to-transfect cells. This talk highlights optimized workflows that streamline cell engineering from discovery to clinical and commercial production.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

MaxCyte, Inc.